Diagnostic and prognostic significance of squamous cell carcinoma antigen in non-small cell lung cancer

Cheah, 1994, Squamous cell carcinoma antigen as an adjunct tumour marker in primary carcinoma of the lung, J. Clin. Pathol., 47, 535, 10.1136/jcp.47.6.535 Diez, 1996, Prediction of survival and recurrence by serum and cytosolic levels of CEA, CA125 and SCC antigens in resectable non-small-cell lung cancer, Br. J. Cancer., 73, 1248, 10.1038/bjc.1996.239 Ebert, 1988, Diagnostic validity of the SCC antigen assays in squamous cell carcinoma of the lung, J. Tumour Marker Oncol., 3, 35 Hanley, 1982, The meaning and use of the area under a receiver operating characteristic (ROC) curve, Radiology, 143, 29, 10.1148/radiology.143.1.7063747 Lai, 1996, Cyfra 21-1 enzyme-linked immunosorbent assay. Evaluation as a tumour marker in non-small cell lung cancer, Chest, 109, 995, 10.1378/chest.109.4.995 Laupacis, 1997, Clinical prediction rules. A review and suggested modifications on methodological standards, J. Am. Med. Assoc., 277, 488, 10.1001/jama.277.6.488 Margolis, 1994, Serum tumour markers in non-small cell lung cancer, Cancer, 73, 605, 10.1002/1097-0142(19940201)73:3<605::AID-CNCR2820730317>3.0.CO;2-T Mino, 1988, Availability of tumour-antigen 4 as a marker of squamous cell carcinoma of the lung and other organs, Cancer, 62, 730, 10.1002/1097-0142(19880815)62:4<730::AID-CNCR2820620415>3.0.CO;2-W Pastor, 1997, Diagnostic value of SCC, CEA and cyfra 21.1 in lung cancer: a Bayesian analysis, Eur. Respir. J., 10, 603, 10.1183/09031936.97.10030603 Sanchez De Cos, 1994, Squamous cell carcinoma antigen (SCC Ag) in the diagnosis and prognosis of lung cancer, Chest, 105, 773, 10.1378/chest.105.3.773 Van der Gaast, 1994, Evaluation of a new tumour marker in patients with non-small-cell lung cancer: Cyfra 21.1, Br. J. Cancer, 69, 525, 10.1038/bjc.1994.95 Youden, 1950, Index for rating diagnostic tests, Cancer, 3, 32, 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3